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Abstract: The physical microenvironment regulates cell behavior during tissue development and 20 
homeostasis. How single cells decode information about their geometrical shape under mechanical 
stress and physical space constraints within tissues remains largely unknown. Here we show that 
the nucleus, the biggest cellular organelle, functions as an elastic deformation gauge that enables 
cells to measure cell shape deformations. Inner nuclear membrane unfolding upon nucleus 
stretching provides physical information on cellular shape changes and adaptively activates a 25 
calcium-dependent mechano-transduction pathway, controlling actomyosin contractility and 
migration plasticity. Our data support that the nucleus establishes a functional module for cellular 
proprioception that enables cells to sense shape variations for adapting cellular behavior to their 
microenvironment.  
 30 
One Sentence Summary: The nucleus functions as an active deformation sensor that enables cells 
to adapt their behavior to the tissue microenvironment. 
 
Main Text:  
Introduction 35 
The 3D shape of an organism is built by active force-generating processes at the cellular level and 
the spatio-temporal coordination of morphodynamic cell behavior. Contractility of the actomyosin 
cell cortex represents a major cellular force production mechanism underlying cellular shape 
change (1), cell polarization (2) and active cell migration dynamics (3). Contractility levels are 
regulated by the activity of non-muscle myosin II motor proteins (4) and are precisely controlled 40 
to tune single cell and tissue morphodynamics during development (5, 6) and tissue homeostasis 
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and disease in the adult organism (7, 8). Still, mechanisms that regulate the set point level of 
cortical contractility on the single cell level remain poorly understood.  
To adjust cortical contractility levels, cells need to make quantitative measures of their mechano-
chemical 3D tissue microenvironment and translate this information into a defined 
morphodynamic output response. During embryogenesis, morphogens that act as chemical 5 
information carriers have attracted major attention (9), modulating cytoskeletal and cellular 
dynamics via receptor signaling pathways that tune protein activities (such as phosphorylation 
states) and/or protein expression levels. In contrast, physical parameters of the 3D tissue niche and 
mechanical forces gain importance as regulators of cellular morphodynamics and myosin II-
dependent cortical contractility levels (10, 11). In vivo, mechanical cell deformation and cellular 10 
packing density in crowded tissue regions has been shown to influence major morphodynamic 
processes such as cortical actomyosin contractility (12, 13), cell division (14-17), cell extrusion  
and invasion (18). Ex vivo studies further provided evidence on the single-cell level that physical 
cell deformation is sufficient to modulate cortical myosin II localization and motor protein activity 
(19, 20) and influence morphodynamic cell behavior (21, 22).  15 
A recent example has been the identification of a fast amoeboid migration mode, termed stable-
bleb migration, that is triggered by an increase in cortical contractility via genetic or physical cell 
perturbation(23). This morphodynamic migration switch was shown to be present in both 
undifferentiated and lineage committed embryonic progenitor cells and was further identified in 
various other cell types (24-29). This suggests that a conserved, yet unknown, mechanosensitive 20 
cellular signaling module regulates myosin II-based cortical contractility and motile cell 
transformation depending on cellular shape deformations in constrained tissue microenvironments.  
 
Cell contractility levels increase upon cell confinement and regulate migration plasticity 
To approach the question of how cells can measure and adaptively respond to physical cell shape 25 
changes within their 3D tissue microenvironments, we established a synthetic approach that 
enables to mimic mechanical cell deformations in controlled 3D microconfinement assays (30). 
Primary progenitor stem cells were isolated from blastula stage zebrafish embryos and cultured in 
planar confinement assays of defined height to mimic various cell deformation amplitudes 
(Fig. S1A). Lowering confinement height in discrete steps increased cell deformation, which 30 
scaled non-linearly with a pronounced enrichment of myosin II at the cell cortex relative to cortical 
actin accumulation (Fig. 1A,B and Fig. S1B-D; Movie 1). Cortical accumulation of myosin II was 
accompanied by an increase in cellular bleb size (Fig. S1E, Movie 1), indicative of an active 
increase in cortical contractility levels depending on confinement height. Myosin II re-localization 
to the cell cortex in confined cells was rapid (t1/2 < 1min, Fig. 1C,D) and temporally stable under 35 
confinement. Of note, distinct plateaus of cortical myosin II enrichment were evident, with 
myosin II re-localization increasing for larger cell deformations (Fig. 1C). A cell confinement 
height below 7 µm caused a pronounced increase in cell lysis during compression, defining a 
maximal threshold deformation of ~30% of the initial cell diameter, given a blastula cell size of 
d~25 µm (Fig. S3H). Overall, these data support that the physical microenvironment defines a 40 
specific set point level of cortical contractility as a function of cell deformation.  
We have previously shown that an increase in myosin II-mediated cortical contractility induced a 
stochastic motility switch into a highly motile amoeboid migration phenotype termed stable-bleb 
mode (23). In accordance with these results, rapid cortical myosin II enrichment in confinement 
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resulted in spontaneous cell polarization which initiated amoeboid cell migration (Fig. 1E,F and 
Fig. S1F,G, Movie 2,3). Polarized cells revealed characteristic actomyosin density gradients from 
the cell front towards the rear accompanied with fast retrograde cortical flows (Fig. S1H, Movie 2, 
3). These cortical flows have been shown to power fast amoeboid migration in polarized cells (23, 
31), while unpolarized cells showed random tumbling with minimal net translocation (Fig. S1F,G, 5 
S2A). These data support that physical cell deformation in confinement is sufficient to increase 
actomyosin network contractility and trigger rapid amoeboid cell migration. 
Release of cell compression induced a rapid re-localization of cortical myosin to the cytoplasm 
(Fig. 1G and S1I), followed by a rapid loss of cell polarization and related migratory capacity 
(Fig. S1G, Movie 4). Interfering with myosin II activity via Blebbistatin inhibited cell polarization 10 
and associated cell motility in confinement (Fig. 1E and S1J), in accordance with a necessary role 
of myosin II-based contractility in cell polarization and migration induced by mechanical cell 
shape deformation. Cortical myosin II enrichment and cell polarization occurred independently of 
caspase activation (Fig. S1K), supporting that morphodynamic changes are not caused by the 
activation of pro-apoptotic signaling programs. Furthermore, transcriptional inhibition did not 15 
block cortical myosin II re-localization and cell polarization (Fig. S1L), indicating that a non-
genetic program is regulating cellular morphodynamics under cell compression. 
During gastrulation, blastoderm embryonic progenitor stem cells specify into different lineages 
(ectoderm, mesoderm, endoderm) and acquire distinct biomechanical and morphodynamic 
characteristics, driving germ layer positioning and shape formation of the embryo (32, 33) (Fig. 20 
2A,B). To test the mechanosensitive response to cell deformation at later developmental stages, 
we obtained different progenitor cell types from embryos via genetic induction or using 
endogenous reporter lines. Under confinement, non-motile ectodermal cells rapidly polarized and 
started to migrate in an amoeboid stable-bleb mode. Similarly, mesendodermal cells underwent a 
fast mesenchymal-to-amoeboid transition in confinement (Fig. 2B-D and Fig. S2A, Movie 3,5). 25 
The fraction of polarized stable-bleb cells and their cell speed was comparable for different 
progenitor cell types in confinement (Fig. S2B,C). Together, these results support that physical 
cell shape deformation in confined tissue microenvironments activates a mechanosensitive 
signaling pathway regulating adaptive cortical contractility levels and morphodynamic migration 
plasticity in pluripotent and lineage committed embryonic stem cells.   30 
 
The cell nucleus is an analog mechanosensor of large cell shape deformation  
We next sought to identify potential mechanisms that control cellular shape deformation sensing 
and adaptive morphodynamic behavior. Cortical myosin II re-localization and amoeboid cell 
transformation occurred on passivated confinement surfaces independently of adhesive substrate 35 
coating (Fig. S2A,C and S3A) and cell-cell contact formation (Fig. S3B). These observations 
support that the activation of cortical contractility in confinement occurs independently of 
adhesion-dependent mechano-transduction pathways (34). The temporal characteristics of 
myosin II re-localization dynamics in confined cells showing a fast, stable and reversible 
accumulation of cortical myosin II (Fig. 1C,D), suggested that shape deformation is sensed by a 40 
non-dissipative cellular element that can rapidly measure and convert gradual cellular shape 
changes into stable contractility response levels.  
The actomyosin cytoskeleton itself has been implicated to act as a mechanosensitive network (20), 
but generally limits deformation sensing due to rapid turnover of the cell cortex (35). To test for 
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the activation of mechanosensitive ion channels we used Gadolinium and GsMTx4, inhibitors of 
stretch activated channels, with GsMTx4 having been shown to block the tension dependent 
Piezo1 channel which is activated following confinement of human cancer cells (36). Treatment 
with both inhibitors showed no significant reduction in cortical myosin II accumulation under cell 
deformation (Fig. S3C), despite the presence of functional Piezo1 channels in these cells as 5 
validated with the Piezo1 specific agonist Yoda (Fig. S3D). 
Interestingly, we observed that cortical myosin II enrichment only started to occur below a 
threshold confinement height (~13 µm) that correlated with the spatial dimension of the nucleus 
(Fig. 3A and S3H). Analyzing nuclear shape change versus cortical myosin accumulation revealed 
a bi-phasic behavior, with a first phase in which the nucleus diameter remained nearly constant 10 
and no myosin II accumulation was observed, and a second phase in which the relative myosin 
accumulation linearly increased with the relative change in nucleus diameter (Fig. 3A,B and S3E). 
In accordance with this observation, we expected a proportional change of nuclear surface ruffling 
upon deformation of an initially spherical nucleus. Measuring of nuclear surface folding by the 
expression of the inner nuclear membrane (INM) protein Lap2b-eGFP revealed that membrane 15 
ruffling was continuously reduced when nucleus deformation started to occur at a threshold 
deformation of ~13 µm (Fig. 3C-E and S3F, Movie 6). In addition, analysis of nucleus membrane 
curvature for confined versus control cells in suspension indicated INM surface unfolding 
(Fig. 3F,G, Movie 6), with no significant difference in total nuclear volume and surface (Fig. S3G). 
Nucleus deformation further correlated with cortical myosin II accumulation in the endogenous in 20 
vivo context during the blastula to gastrula transition, when a gradient of cellular packing density 
appears from the animal pole towards the lateral margin (37) (Fig. S2D,E). 
To further probe the dependence of cortical myosin II accumulation on nucleus size, we dissociated 
primary embryonic stem cells from early and late blastula stages as cells reduce their size in 
consecutive rounds of early cleavage divisions (Fig. S3H). Deforming cells of different sizes under 25 
similar confinement heights revealed that myosin II accumulation is correlated with relative 
changes in nucleus deformation but not cell deformation (Fig. 4A,B). To test a functional role of 
the nucleus in regulating cortical contractility levels during cellular shape deformation, we 
analyzed cortical myosin II accumulation in mitotic cells that present a disassembled nuclear 
envelope. To arrest cells in mitosis and further increase the percentage of mitotic cells, we used 30 
Nocodazole, a microtubule disrupting drug. Confinement of mitotic cells (either spontaneous or 
Nocodazole-induced) did not trigger a cortical myosin II accumulation at 7 µm confinement height 
compared to interphase blastula cells (Fig. 4C) or cell polarization (Fig. S3I), although they 
accumulated myosin II (Fig. 4D) and polarized (Fig. S3I) in response to LPA, a potent activator 
of Rho/Rock signaling that has previously been shown to induce rapid cortical myosin II 35 
enrichment and amoeboid migration in zebrafish embryonic progenitor stem cells (23). During 
entry into mitosis, cells further gradually lost cortical myosin II accumulations which temporally 
correlated with the start of nuclear envelop breakdown (Fig. 4E). Altogether, these data show that 
myosin II enrichment is associated with nuclear shape deformation and stable INM membrane 
unfolding. This suggests that the nucleus functions as a continuous non-dissipative sensor element 40 
of cell deformation involved in the mechanosensitive regulation of cortical contractility levels and 
cellular morphodynamics.  
To directly test biophysical characteristics of the nucleus, we developed an assay to probe 
intracellular nucleus mechanics by optical tweezer measurements. For this purpose, latex beads of 
1 µm size were injected into 1-cell stage embryos that dispersed across embryonic cells during 45 
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early cleavage cycles and acted as intracellular force probes to measure rheological properties of 
the nucleus (Fig. S4A). Trapezoidal loads were measured for cells in suspension and under 10 µm 
confinement (Fig. S4B-E). The recorded force followed the fast-initial indentation to reach a peak 
force before it relaxed to a non-zero constant force-plateau. The relaxation time remained 
unchanged between suspension (t=6.08s +/- 1.1s) and confined cells (t =4.00s +/- 0.6s) (Fig. S4D-5 
H), suggesting a passive but rapid (second scale) relaxation of a viscous component. The force-
plateau on long timescale corresponds to an elastic component of the nucleus (Fig. S4I), in line 
with previous measurements that identified an elastic behavior of the nucleus (38) that can act as 
a cellular strain-gauge. In addition, we observed that INM unfolding was stable over a 
measurement period of 60 min (Fig. S4J) under mechanical cell deformation, supporting that INM 10 
stretch does not relax over extended time periods.  
 
Nuclear deformation activates a calcium-dependent mechanotransduction pathway 
regulating myosin II activity 
We next aimed at identifying nucleus deformation-dependent signaling pathways that link the 15 
spatio-temporal correlation of nuclear shape changes with fast myosin II activation and changes in 
morphodynamic cell behavior. Our previous observations suggested that nucleus deformation and 
associated mechanosensitive processes at the INM interface are involved in the regulation of 
myosin II activity and cortical contractility. Among a set of molecules tested under confinement 
conditions (Table S1), we identified cytosolic phospholipase A2 (cPLA2) as a key molecular target 20 
mediating the activation of cortical myosin II enrichment (Fig. 5A-B) and amoeboid cell 
transformation under cell compression (Fig. 5C). Inhibition of cPLA2 by pharmacological 
interference using Pyrrophenone robustly blocked cortical myosin II re-localization under varying 
confinement heights (Fig. S5A). Furthermore, we observed a significant reduction of cortical 
myosin II levels in confined cells by morpholino (MO) interference with cPLA2, while 25 
overexpression of cPLA2 mRNA rescued the morphant phenotype and led to a comparable myosin 
II accumulation as in control cells (Fig. 5A,B). Residual myosin II activation in cells obtained 
from morphant embryos suggests a maternal contribution of cPLA2 protein in the early embryo 
which cannot be targeted by MO interference. To exclude that other mechanisms such as structural 
changes in the actin network prevent cortical myosin II re-localization under cPLA2 inhibition, we 30 
added LPA as an exogenous myosin II activator to cPLA2 inhibited cells. Under this condition, 
myosin II was strongly accumulated at the cell cortex (Fig. S5B,C) and induced cell polarization 
associated with amoeboid motility (Fig. 5C). These data support that myosin II can be activated 
by extrinsic pathways when cPLA2 signaling is inhibited and remains competent to bind to the cell 
cortex. 35 
Recent work identified that the activation of pro-inflammatory signaling during leucocyte 
recruitment to wounding sites is regulated by tension-sensitive binding of cPLA2 to the INM (39). 
We thus tested a role of cPLA2 in the nucleus by generating a modified cPLA2 construct containing 
a nuclear export sequence (NES). Using Leptomycin B as a blocker of nuclear export, an 
accumulation of cPLA2-NES-GFP within the nucleus was observed, showing a concomitant 40 
increase of cortical myosin II levels in confined cells (Fig. 6A,B). These data support, that cPLA2 
localization in the nucleus is required for myosin II enrichment at the cortex. 
We further validated that cortical myosin II enrichment in cells of different sizes (early versus late 
blastula cells) and different embryonic cell lineages (mesendoderm/ectoderm cells) depends on the 
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activation of cPLA2 signaling. Pharmacological inhibition of cPLA2 activity blocked cortical 
myosin re-localization in confined cells (Fig. 6C) and strongly reduced cell polarization and 
associated migration competence (Fig. S2B), supporting a consistent role of cPLA2 activation 
under physical cell deformation across early to late developmental stages. These data support that 
activation of cPLA2 signaling in the nucleus mediates adaptive cytoskeletal and morphodynamic 5 
behavior under cell deformation.  
Arachidonic acid (AA) is the primary cleavage product generated by cPLA2 activity (40). To 
directly validate whether nucleus deformation in confinement triggers cPLA2 activity, we 
measured the release of AA by Raman spectroscopy. The analysis of Raman spectra confirmed the 
specific production of AA in confined cells (Fig. 6D and Fig. S5E), with the increase in AA 10 
production in confined versus control cells being specifically blocked in the presence of cPLA2 
inhibitor (Fig. 6E). We further observed that AA was exclusively detected in the cytoplasm of 
confined cells, arguing that AA is directly released from nuclear membranes into the cytoplasm. 
These data support that cell confinement leads to enhanced cPLA2 activity and production of 
arachidonic acid associated with INM unfolding and stretching of the nucleus surface. 15 
AA has been implicated to regulate myosin II activity both directly (41) and indirectly via protein 
phosphorylation (42). We tested the involvement of Rho/Rho associated protein kinase (ROCK) 
and Calcium/Myosin light chain kinase (MLCK) signaling that act as key regulatory pathways of 
myosin II activity (4). MLCK inhibition showed no significant effect on myosin II enrichment in 
confined cells, while a pronounced reduction of cortical myosin II recruitment was observed when 20 
using Staurosporin, a general kinase inhibitor, and under specific inhibition of Rho activity 
(Fig. 6F). Using a RhoA-Fret sensor further indicated an increased RhoA activity in confined cells 
versus control cells in suspension which was significantly reduced in the presence of cPLA2 
inhibitor in confined cells (Fig. S5F). These data support that AA production by cPLA2 activity 
engages upon nuclear envelope unfolding, regulating phosphorylation-dependent myosin II 25 
activity at the cell cortex. AA and its metabolic products have been widely implicated in para- and 
autocrine signaling functions involving GPCRs (43). We assessed the role of AA product release 
by compressing cells directly under micropillars at an approximate height of 7 µm, leading to 
confined and non-confined cells in close proximity (Fig. S5G). Interestingly, while confined cells 
showed high levels of cortical myosin II and amoeboid cell transformation, non-confined cells in 30 
direct contact revealed no alterations in cortical myosin II and cellular morphodynamics (Fig. 
S5H). These results support that cPLA2-dependent myosin II activation does not depend on the 
release of diffusible signals and regulates cellular morphodynamics via a cell autonomous increase 
of cortical contractility under cell deformation in confinement.  
Interference with intracellular calcium levels by addition of BAPTA-AM or in combination with 35 
cPLA2 inhibitor blocked myosin II enrichment in confined cells, without altering cortical myosin II 
levels in unconfined control cells (Fig. S5I). LPA stimulation of BAPTA-AM treated cells 
confirmed that myosin II can be activated by the Rho-ROCK signaling pathway in the absence of 
intracellular calcium and remains competent to bind the cell cortex (Fig. S5C). Similarly, chelating 
extracellular calcium reduced cortical myosin II re-localization, while depletion of internal 40 
calcium stores using Thapsigargin led to a slight increase in myosin II enrichment in confinement 
(Fig. S5I). The addition of ionomycin showed that high intracellular calcium levels, in the absence 
of cellular shape deformation, were not sufficient to evoke AA production (Fig. S5J) and cortical 
myosin II enrichment (Fig. S5B,D). This suggests that intracellular calcium has a permissive 
function for cPLA2 association with the INM and increasing cortical contractility under cell 45 
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confinement. Our findings are in line with the observation that cPLA2 contains a calcium-
dependent C2 domain that modulates protein binding to the INM (44-46), which has been shown 
to get further enhanced and stabilized by mechanical stretching of the nucleus (39). Consistently, 
cPLA2 showed a transient localization to the INM in the presence of ionomycin, while additional 
mechanical stretch due to hypotonic swelling or cell confinement induced a stable association with 5 
the INM (Fig. S3J-K). 
 
INM unfolding and nucleus positioning enable to decode different types of cell shape 
deformations 
To study if INM unfolding under cell confinement was sufficient to trigger cPLA2 activity, we 10 
measured cortical myosin II levels and amoeboid migration competence under hypotonic swelling 
of cells. Quantification of nuclear shape parameters (size, volume, surface) revealed that hypotonic 
swelling induced comparable nuclear surface expansion and INM unfolding as nucleus 
deformation under a confinement height of 7 µm (Fig. S6A-C). Interestingly, cortical myosin II 
levels in hypotonic conditions (Fig. 7A, Movie 7) and associated changes in bleb size (Fig. S6D) 15 
and cell polarization rate (Fig. 7C) were significantly lower compared to cells deformed at 7 µm 
confinement height. These observations suggest that nuclear envelope unfolding alone is not 
sufficient to trigger high levels of cortical myosin II enrichment under isotropic cell stretching in 
hypotonic conditions versus anisotropic cell deformation in confinement.  
Comparing intracellular calcium levels between deformed cells in confinement and under 20 
hypotonic conditions showed a pronounced increase in intracellular calcium concentrations in 
confined cells, with a specific calcium increase in the cell nucleus (Fig. 7B and Fig. S6E). This 
observation suggests that the level of intracellular calcium can modulate morphodynamic cellular 
responses to different mechanical shape deformations. Of note, ectopically increasing intracellular 
calcium levels under hypotonic conditions via the addition of ionomycin led to a pronounced and 25 
rapid increase in cortical myosin II enrichment in a cPLA2-dependent manner (Fig. S6F, Movie 7) 
that triggered spontaneous cell polarization (Fig. 7C,D and S6G). Similar to cells in confinement, 
cell polarization under this condition was associated with a rapid transformation of non-motile 
cells into a highly motile stable-bleb amoeboid mode with fast migration speed under confinement 
ex vivo and in vivo (Fig. 7E and S6H,I,M, Movie 7,8). Raman spectroscopy to directly measure 30 
cPLA2 activity confirmed that hypotonic stress increased AA levels (Fig. S5K) in a cPLA2-
dependent manner (S5L), with addition of ionomycin in hypotonic conditions further increasing 
AA production (S5M). Relative measured AA levels further directly correlated with cortical 
myosin II levels (Fig. S5N). Together, these data reveal that intracellular calcium levels are 
differentially regulated under distinct shape deformations and modulate cPLA2 activity under 35 
similar INM stretch: uniaxial compression in confinement induces high intracellular calcium levels 
specifically in the nucleus, while isotropic radial stretch in hypotonic stress conditions leads to a 
lower intracellular calcium levels. Independently modulating nucleus deformation and calcium 
levels under different shape deformations confirmed that both parameters engage synergistically 
to regulate cortical contractility (Fig. 8A) and cellular dynamics under mechanical stress (Fig. 7E), 40 
thereby enabling a cell to distinguish between different types of shape deformation and to acquire 
a specific morphodynamic response. 
Intracellular nucleus positioning appeared a promising candidate to differentially modulate 
calcium levels. ER-plasma membrane (ER-PM) proximity has been implicated as an important 
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regulator of cellular calcium signaling (47). Visualization of membrane proximal ER structures 
showed that the ER was highly dynamic under conditions of low confinement but was increasingly 
immobilized between the nucleus-PM interface for larger cell deformations in confinement 
(Movie 9). In addition, the expanding nucleus contact area close to the plasma membrane closely 
correlated with an intracellular calcium increase (Fig. S6J). We speculated that STIM-Orai, with 5 
STIM proteins located at the endoplasmic reticulum (ER) and Orai proteins representing calcium-
selective plasma membrane (PM) calcium channels, could be involved in cellular calcium 
regulation in confined cells. STIM-Orai proteins have an established function in store operated 
calcium entry (SOCE) upon depletion of calcium from the ER which are mediated via ER-PM 
proximity (48, 49). Analysis of STIM-Orai protein localization revealed that both proteins 10 
accumulate at the interface between the nucleus and plasma membrane in confined cells at 7 µm 
(Fig. S6K,L). In contrast, we observed a homogenous distribution of both channels in cells under 
13 µm confinement height when the ER was not spatially confined between the nucleus and PM. 
These data support that ER immobilization is associated with the specific enrichment of STIM-
Orai in the ER-PM contact region where mechanical ER confinement occurs. Inhibition of the 15 
STIM-Orai complex by using 2APB further blocked myosin II enrichment under cell deformation 
in confinement (Fig. S5I). Our observations support that mechanical compression of the cell 
nucleus induces a tight connectivity between ER-PM structures and STIM-Orai localization at the 
ER-PM contact interface involved in the upregulation of intracellular calcium levels in confined 
cells.  20 
 
Conclusions 
Our data support that the nucleus establishes a core element to measure cellular shape deformation 
via two key physical parameters: 1) nuclear shape deformation leading to INM unfolding and 2) 
intracellular spatial positioning of the nucleus. In this model, INM unfolding under nuclear shape 25 
change allows for the deformation-dependent activation of cPLA2 signaling, whereby cPLA2 
activity is modulated by intracellular calcium levels set by nucleus-PM proximity (Fig. 8B and 
S7A). The parameter space of these two variables (INM unfolding and calcium levels) provides a 
unique identifier for a cell to decode distinct shape deformations as exemplified on anisotropic cell 
deformation in confinement versus isotropic hypotonic cell stretching, allowing cells to acquire a 30 
unique adaptive response depending on the type of physical shape deformation (Fig. S7B). 
Biochemical, physical and mechanical cues in the surrounding of a cell create manifold 
information for cells which is continuously sensed, integrated and transduced to allow for complex 
cellular functioning. Here we show that the cell nucleus functions as a cellular mechano-gauge for 
precisely decoding cellular shape changes, allowing cells to adaptively and rapidly tune 35 
cytoskeletal network properties and morphodynamic behavior within their 3D tissue 
microenvironment during development. This mechanism lays a foundation for functional 
principles underlying cellular proprioception that, comparable to the sensing of spatio-temporal 
changes in body posture and movement (50), enable a precise interpretation of shape changes on 
the single cell level.  40 
The nucleus, being the largest organelle within the cell, represents a prominent structure to transmit 
and modulate mechanosensitive processes (51-55), and nucleus deformation has been shown to 
influence nuclear transport and cell differentiation (56-58), chromatin (59-61), migration (62-66) 
and pathfinding in constrained environments (67). Our findings support that nucleus deformation 
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and its intracellular positioning establish a cellular sensing module that equips cells to rapidly and 
reversibly adapt their dynamic response to shape fluctuations. This “nuclear ruler pathway” was 
also identified in an accompanying study (68), supporting its conservation between embryonic and 
differentiated cells in the adult organism. The observation of a rapid contractile cell response upon 
cell squeezing in confinement which is followed by fast amoeboid motility is reminiscent of a 5 
“cellular escape reflex” that enables cells to cope with physical constraints and acute deformations 
of their shape. Such a mechanism might be relevant for various biological processes associated 
with migration plasticity of cancer and immune cells in constrained 3D tissue niches (69-72) 
mechano-chemical feedback processes during morphogenesis (73) and homeostatic tissue 
functions such as cell density regulation (74), which require accurate mechanisms to detect 10 
variations in cellular size and shape and multicellular packing density in crowded 3D tissues.  
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Figure 1. Cell deformation in confined environments defines cell contractility, polarization 
and fast amoeboid cell migration. (A) Relative cortical myosin II enrichment for decreasing 
confinement height in un-polarized progenitor cells (N=477 (suspension, unconfined); N=56 (18 5 
µm); N=35 (16 µm); N=103 (13 µm); N=131 (10 µm); N=49 (8.5 µm); N=348 (7 µm)). 
Significance values are with respect to the suspension condition. Black line shows a mono-
exponential fit with offset to the data. (B) Exemplary confocal fluorescence images of control 
progenitor stem cells in suspension (Susp.) and indicated confinement heights expressing Myl12.1-
eGFP (myosin II). White arrows point at cellular blebs. (C) Temporal dynamics of cortical myosin 10 
II recruitment upon mechanical confinement at time t=0 at indicated heights. Thick lines 
correspond to the mean and areas to the standard error of the mean (sem). N>50 cells for all 
conditions. (D) Exemplary cross-sectional time-lapse images of myosin II-eGFP expressing cells 
under 7 µm confinement. (E) Percentage of polarized motile stable-bleb cells in suspension at 
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indicated confinement heights and myosin II inhibition (blebbistatin) at 7 µm (each N>500). (F) 
Representative time-lapse images of a myosin II-eGFP expressing cell undergoing spontaneous 
stable-bleb cell polarization and migration initiation. Dashed line shows the stable-bleb cell front 
and red arrow points in the direction of movement. (G) Relative cortical myosin II enrichment 
during reversible cell confinement. Cells were confined for 15 min before confinement was 5 
released and cortical myosin II levels were measured at t0 (0-5 min) and at t0+Dt (30-60 min) after 
release. ***p<0.0001, **p<0.001, *p<0.01, not significant (n.s.). All scale bars 10 µm. 
 
  





Figure 2. Physical confinement triggers amoeboid migration in different cell lineages. (A) 
Sketch of the developing zebrafish embryo at sphere (4 hpf), shield (6 hpf) and 75% epiboly (8 
hpf) stage. (B) Exemplary confocal and bright field images of mesodermal cells in vivo expressing 5 
Lyn-Tomato (magenta, membrane) and GFP (green) under the mezzo promoter (left), induced 
mesendodermal cells in vitro plated on a 2D fibronectin-coated surface (middle) and under 7 µm 
confinement (right), asterisk points at stable-bleb cell front. (C) Relative cortical myosin II 
intensity for mesendodermal and ectodermal progenitor cells in control suspension and 
confinement conditions. (D) Exemplary confocal images of stable-bleb polarized (top) and non-10 
polarized (bottom) progenitor cell types expressing myosin II-eGFP under 7 µm confinement. 
From left to right: ectoderm, endoderm and mesoderm cells. Dashed line and yellow asterisks 
indicate the stable-bleb cell front and red arrows the direction of cell migration. ***p<0.0001, 
**p<0.001, *p<0.01, not significant (n.s.). All scale bars 10 µm. 
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Figure 3. Nuclear envelop unfolding is associated with increasing cortical contractility. (A) 
Double boxplot of relative cortical myosin II enrichment (left axis, grey) and relative nuclear 
diameter (right axis, green) for decreasing confinement height. Statistical test for relative nuclear 5 
diameter performed with respect to suspension (N=144 (suspension); N=44 (18 µm); N=32 (16 
µm); N=37 (13 µm); N=45 (10 µm); N=37 (8.5 µm); N=50 (7 µm)). Statistical tests for cortical 
myosin II levels and experimental N related to Fig.1A. (B) Exemplary confocal top views (x-y) 
and lateral views (y-z) of progenitor stem cells expressing myosin II-eGFP stained with DNA-
Hoechst and ER-TrackerRed in 13 µm and 7 µm confinement. (C) Illustration showing the 10 
unfolding of the inner nuclear membrane (INM) with increasing cell confinement. (D) Nuclear 
area to perimeter ratio (top) and nuclear invagination ratio (bottom) for increasing confinement. 
(E) Exemplary confocal images of cells expressing Lap2B-eGFP under varying cell deformation. 
(F) Curvature analysis of nuclear shape for 20 consecutive frames (tlag=10 s) for unconfined 
(suspension, top) and 7 µm confined nuclei (bottom). (G) Histogram of nuclear curvature for 15 
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unconfined and 7 µm confined nuclei related to panel F with N=10 cells for each condition (p<10-
12, ***). ***p<0.0001, **p<0.001, * p<0.01, not significant (n.s.). All scale bars 10 µm despite 
5 µm in (B). 
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Figure 4. Nucleus size and integrity determine the morphodynamic cell response to 
confinement. (A) Relative cortical myosin II intensity with respect to cell deformation as defined 
by the ratio of cell size/confinement height (left) and nucleus deformation (right) measured via 5 
relative nucleus diameter increase (right) for cells dissociated from embryos at high-oblong 
(3.3 hpf) and sphere stage (4 hpf) and cultured under similar confinement heights as indicated. 
Data points and error bars indicate mean and standard error of the mean (sem); (3.3 hpf: 16 µm 
N=58, 13 µm N=61; 4 hpf: 16 µm N=44, 13 µm N=60, 10 µm N=45). The Pearson correlation 
coefficient in between myosin II intensity and nuclear deformation is 0.48. (B) Exemplary confocal 10 
images of progenitor cells expressing myosin II-eGFP under 16/13 µm confinement dissociated 
from 4 hpf (top) and 3.3 hpf (bottom) embryos. Dashed lines outline cell nuclei. (C) Relative 
cortical myosin II enrichment for interphase and mitotic cells under 7 µm confinement cultured in 
suspension (control) in the presence of 1 µM Nocodazole. Exemplary confocal images of 
progenitor cells expressing myosin-II-eGFP in interphase (yellow asterisk) or during mitosis (cyan 15 
Submitted Manuscript: Confidential 
17 
 
asterisk) under 7 µm confinement. (D) Exemplary confocal images of progenitor unpolarized (top) 
and polarized (bottom) cells expressing myosin-II-eGFP during mitosis treated with 1 µM 
Nocodazole and 50 µM LPA. Dashed line shows the stable-bleb cell front. (E) Cortical myosin II 
intensity of N=7 cells undergoing mitosis and representative confocal time lapse images of cells 
expressing myosin-II-eGFP and H2A-mCherry at indicated time points (t=0: time of nuclear 5 
envelope breakdown). The arrows point at the cell cortex with cortical myosin enrichment (t=-
1min) or loss of cortical myosin levels (t=7.5min). Data points and error bars indicate mean and 
standard error of the mean. ***p<0.0001, **p<0.001, * p<0.01, not significant (n.s.). All scale 
bars 10 µm. 
 10 
  





Figure 5. Nucleus deformation activates a mechanosensitive lipase signaling pathway 
regulating myosin II activity. (A) Relative cortical myosin II intensity for progenitor cells 
cultured in suspension versus 7 µm confinement conditions for control cells (DMEM), with cPLA2 5 
inhibitor, or injected with cPLA2 MO and cPLA2 MO + cPLA2 mRNA. (B) Exemplary confocal 
images of progenitor cells expressing myosin II-eGFP related to (A) for indicated conditions. (C) 
Percentage of stable-bleb polarized cells for control cells under 7 µm confinement and in the 
presence of cPLA2 inhibitor or unconfined (suspension) cells stimulated with 50 µM LPA. For all 
conditions N>200. ***p<0.0001, **p<0.001, *p<0.01, not significant (n.s.). All scale bars 10 µm. 10 
 
  





Figure 6. cPLA2 activity at the inner nuclear membrane generates AA as a metabolite 
regulating cortical contractility in confinement. (A) Relative cortical myosin II fluorescence 
intensity for cells dissociated from controls (un-injected) embryos or embryos injected with cPLA2 5 
MO, cPLA2 MO + cPLA2-NES-GFP mRNA (RNA) and with or without addition of Leptomycin 
B (Lb). (B) Exemplary confocal fluorescence images of cell expressing myosin II-mCherry (right) 
and cPLA2-NES-GFP (left) under 7 µm confinement with (top) or without (bottom) the addition 
of Lb. (C) Relative cortical myosin II fluorescence intensity upon cPLA2 inhibition for cells 
dissociated at 3.3 hpf, induced mesendoderm or ectoderm cells in suspension and upon 10 
confinement at indicated height. (D, E) Scores of Raman component associated to AA in 
suspension (unconfined, N=24) and confined cells (10 µm, N=28) and (H) in control confinement 
condition (Ctrl, N=52) or treated with cPLA2 inhibitor (N=22). Red lines indicate mean and sem. 
(F) Relative cortical myosin II intensity for control cells and different chemical (Y-27637, M-L7, 
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Staurosporine) or genetic interference (dnRhoA) with myosin II regulators. ***p<0.0001, 
**p<0.001, *p<0.01, not significant (n.s.). All scale bars 10 µm. 
  





Figure 7. Nucleus stretch and intracellular positioning enable an adaptive cellular 
response to different types of physical cell deformation. (A) Relative cortical myosin II 
enrichment for progenitor cells cultured under different osmolarity conditions. (B) Normalized 5 
cell (left) and nuclear (right) Ca2+ levels (Calbryte520) for control (Ctrl) and hypotonic (0.5 x) 
conditions and mechanical confinement (13 µm, 7 µm). (C) Percentage of stable-bleb polarized 
cells in isotonic and hypotonic (0.5 x) conditions for cells cultured in DMEM (Ctrl) or 
supplemented with 1 µM ionomycin. N>1000 cells for all conditions. (D) Exemplary confocal 
images of cells expressing myosin II-eGFP in isotonic (ctrl, top-left), hypotonic (bottom-left) 10 
and hypotonic conditions supplemented with ionomycin treatment (right): non-polarized cell 
(top) and stable-bleb polarized cell (bottom). (E) Sketch of cell polarization and motile cell 
behavior in 2D (top) versus 3D confined environments (bottom) and for control conditions 
(isotonic media; first column) versus cPLA2 interference (second column) and hypotonic 
condition alone (third column) or in the presence of ionomycin (fourth column). ***p<0.0001, 15 
**p<0.001, *p<0.01, not significant (n.s.). Scale bars 10 µm. 





Figure 8. INM unfolding and intracellular calcium levels enable cells to decode isotropic 
stretch versus cell squeezing in confinement. (A) Normalized relative cortical myosin II 
fluorescence intensity as a function of nucleus unfolding and normalized Ca2+ (Calbryte) 5 
intensity for different physical cell deformations (dark blue: 7 µm; light blue: 13 µm 
confinement; yellow: 7 µm confinement + Bapta-AM; red: hypotonic (0.5x) condition; 
magenta: hypotonic condition (0.5x) + ionomycin). Data indicate mean and sem. The gray area 
sketches the relation between cortical myosin II and nuclear deformation versus intracellular 
calcium levels. (N: calcium data related to Fig. 4B, except for hypo + ionomycin (N=41) and 10 
Bapta-AM + 7 µm N=9; for nuclear unfolding related to Fig. 2D, Fig S6B and for cortical 
myosin II levels to Fig. 1A, S5I, 4A, S6F). (B) Sketch depicting how nucleus deformation and 
intracellular nucleus positioning correlate with INM unfolding and intracellular calcium levels, 
which differentially regulate cortical contractility and cellular morphodynamics. ***p<0.0001, 
**p<0.001, *p<0.01, not significant (n.s.). Scale bars 10 µm. 15 
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Materials and Methods 
 
Zebrafish Maintenance Zebrafish (Danio rerio) were maintained as previously described (75). 
Embryos were kept in E3 medium at 25°C–31°C prior to experiments and staged based on 
morphological criteria (76) and hours post fertilization (hpf). Wild type embryos were obtained 5 
from the AB strain background. All protocols used have been approved by the Institutional Animal 
Care and Use Ethic Committee (PRBB–IACUEC) and implemented according to national and 
European regulations. All experiments were carried out in accordance with the principles of the 
3Rs.  
Transgenic fish lines The following transgenic lines were used: Tg(actb2:Lifeact-GFP) (77), 10 
Tg(actb2:Myl12.1-eGFP) (78), Tg(actb2:Myl12.1-mcherry) (4), Tg(mezzo:eGFP) (23), 
Tg(actb2:Lyn-TdTomato) (79). All progenitor cells expressing Myl12.1-eGFP (Myosin II) and 
Lifeact-GFP (Actin) were obtained from Tg(actb2:Myl12.1-eGFP) and Tg(actb2:Lifeact-GFP). 
Cell culture To culture progenitor cells, embryos were manually dechorionated in E3 buffer at 
sphere stage (4 hpf) or different stages if indicated. Five to twenty embryos were transferred to 15 
DMEM-F12 (with L-Glut and 15mM HEPES, without sodium bicarbonate and phenol red) culture 
medium (Sigma) and mechanically dissociated by manual tapping followed by centrifugation at 
200 g for 3 min.  
Sample preparation and surface coatings The following products for surface coatings at the 
indicated concentration have been used: 0.5 mg/ml PLL(20)-g[3,5]-PEG(2) (Susos) and 0.2 mg/ml 20 
fibronectin (Sigma-Aldrich). Prior to PLL-PEG coating, both coverslips and dishes were plasma 
cleaned. Uncoated or PLL-coated glass dishes #1.5 were purchased from MatTek (MatTek 
Corporation). 
Cell confiner Cells were confined using a dynamic confiner (4DCell) similar to previously 
established planar microconfinement methods (30). In order to confine cells at different heights, 25 
multiple Si molds were produced by photolithography in a clean room (Nanofabrication 
laboratory, ICFO) by depositing a SU-8 resin on a silicon wafer. In brief, a photomask with the 
desired geometry was created. Confinement coverslips were prepared with polydimethylsiloxane 
(PDMS) with the following heights: 18, 16, 13, 10, 8.5 and 7 µm. Coverslips were always plasma 
cleaned, coated with PLL-PEG if not indicated otherwise and equilibrated in DMEM prior to each 30 
experiment. A pressure pump (AF1 – Microfluidic pressure pump, Elveflow) together with the 
ESI software was used to change the pressure for tuning the confinement heights. For Raman 
measurements and optical tweezers two coverslips separated with microbeads or with a PDMS 
membrane have been used (height h=10 µm).  
Reagents and inhibitor treatments Pharmacological inhibitors were used at the following 35 
concentrations: 1 µM cPLA2 inhibitor (Pyrrophenone, Merck-Millipore), 10 µM Bapta-AM 
(Cayman), 10 µM Blebbistatin (+) (Tocris Bioscience), 10 µM Y-27632 (Tocris Bioscience), 
10 µM ML-7 hydrochloride (Tocris Bioscience), 1 µM Nocodazole (Sigma), 50 nM LeptomycinB 
(Sigma-Aldrich), 1 µM Ionomycin (Sigma-Aldrich), 1 µM Thapsigargin (Thermofisher), 10 µM 
GsMTx4 (Tocris), 50 µM 2-APB (Biogen-Santa Cruz), 10 µM Gadolinium chloride (Tocris), 40 
2 µM Actinomycin D (PanReac), 100 µM Z-VAD(OMe)-FMK (Abcam), 1 µM Staurosporine 
(Abcam), 1-oleoyl lysophosphatidic acid (LPA, Tocris Bioscience) was used at the indicated 
concentrations. Measurements were done directly after exposure to MLCK inhibitor, GsMTx4, 
Ionomycin, LPA; all the other inhibitors have been pre-incubated for 30 min and 60 min for Y-
27632 prior to experiments.  45 
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Fluorescence staining Calbryte520 (AAT BIOQUEST) was used to study calcium dynamics. The 
staining kit-Red Fluorescence-Cytopainter (ER Tracker, Abcam) or ER-Tracker™ Green 
(BODIPY™ FL Glibenclamide) were used to visualize the endoplasmic reticulum respectively for 
confocal 3D colors imaging and for TIRF microscopy experiment. DNA-Hoechst (Thermofisher) 
was used to stain the cell nucleus. Cells were incubated with Calbryte520 for 20 min, with ER-5 
tracker for 30 min and with DNA-Hoechst for 7-10 min as reported in the corresponding protocols 
and at the indicated concentrations. After incubation, cells were washed, centrifuged at 200 g for 
3 min and re-suspended in DMEM media. 
Variable osmotic culture conditions D-Mannitol (Sigma) was diluted in DMEM in order to 
obtain a culture medium with an osmolarity of approx. 450 mOsm/l (corresponding to a 1.5x 10 
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